UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 225

Sortiert nach

Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities

Cancer treatment reviews, 2020-08, Vol.88, p.102054-102054, Article 102054

2020

Volltextzugriff (PDF)

LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma

Analytical chemistry (Washington), 2016-02, Vol.88 (3), p.1871-1877

2016

Volltextzugriff (PDF)

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Journal of clinical oncology, 2012-10, Vol.30 (30), p.3752-3763

2012

Volltextzugriff (PDF)

Cardiovascular toxicity caused by cancer treatment: strategies for early detection

The lancet oncology, 2009-04, Vol.10 (4), p.391-399

2009

Volltextzugriff (PDF)

Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life

Journal of clinical oncology, 2023-07, Vol.41 (19), p.3512-3522

2023

Volltextzugriff (PDF)

Metformin: Taking away the candy for cancer?

European journal of cancer (1990), 2010-09, Vol.46 (13), p.2369-2380

2010

Volltextzugriff (PDF)

Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage

PloS one, 2015-01, Vol.10 (1), p.e0115372-e0115372

2015

Volltextzugriff (PDF)

Antibody positron emission tomography imaging in anticancer drug development

Journal of clinical oncology, 2015-05, Vol.33 (13), p.1491-1504

2015

Volltextzugriff (PDF)

Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1587-1597

2021

Volltextzugriff (PDF)

Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors

International journal of radiation oncology, biology, physics, 2016-04, Vol.94 (5), p.1061-1072

2016

Volltextzugriff (PDF)

Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4370-4378

2007

Volltextzugriff (PDF)

The metabolic syndrome in cancer survivors

The lancet oncology, 2010-02, Vol.11 (2), p.193-203

2010

Volltextzugriff (PDF)

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy

British journal of cancer, 2020-11, Vol.123 (11), p.1599-1607

2020

Volltextzugriff (PDF)

Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

Molecular cancer therapeutics, 2020-02, Vol.19 (2), p.590-601

2020

Volltextzugriff (PDF)

The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective

Journal of translational medicine, 2019-11, Vol.17 (1), p.374-374, Article 374

2019

Volltextzugriff (PDF)

Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

Investigational new drugs, 2020-10, Vol.38 (5), p.1454-1462

2020

Volltextzugriff (PDF)

Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies

Scientific reports, 2020-11, Vol.10 (1), p.18938, Article 18938

2020

Volltextzugriff (PDF)

VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment

Cancer research (Chicago, Ill.), 2011, Vol.71 (1), p.143-153

2011

Volltextzugriff (PDF)

Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy

The pharmacogenomics journal, 2021-04, Vol.21 (2), p.152-164

2021

Volltextzugriff (PDF)

miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy

Cells (Basel, Switzerland), 2019-10, Vol.8 (10), p.1221

2019

Volltextzugriff (PDF)

Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Journal of clinical oncology, 2006-01, Vol.24 (3), p.467-475

2006

Volltextzugriff (PDF)

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Journal of clinical oncology, 2006-05, Vol.24 (15), p.2276-2282

2006

Volltextzugriff (PDF)

Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study

Breast (Edinburgh), 2021-08, Vol.58, p.138-146

2021

Volltextzugriff (PDF)

Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study

Clinical cancer research, 2009-09, Vol.15 (17), p.5584-5590

2009

Volltextzugriff (PDF)

Endothelial Damage in Long-Term Survivors of Childhood Cancer

Journal of clinical oncology, 2013-11, Vol.31 (31), p.3906-3913

2013

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(132)
Humans
(125)
Oncology
(98)
Male
(84)
Adult
(76)
Middle Aged
(69)
Female
(54)
Aged
(42)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Tumors
(36)
Testicular Neoplasms - Drug Therapy
(35)
Chemotherapy
(34)
Testicular Cancer
(27)
Adolescent
(26)
Cancer
(26)
Young Adult
(26)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(23)
Patients
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities

LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Cardiovascular toxicity caused by cancer treatment: strategies for early detection

Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life

Metformin: Taking away the candy for cancer?

Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage

Antibody positron emission tomography imaging in anticancer drug development

Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors

Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

The metabolic syndrome in cancer survivors

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy

Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective

Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies

VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment

Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy

miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy

Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study

Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study

Endothelial Damage in Long-Term Survivors of Childhood Cancer

Suchergebnisse filtern